Cardiovascular Consequences of Obese and Nonobese Obstructive Sleep Apnea

Medical Clinics of North America

Volumn 94, Issue 3, 2010, Pages 465-478

  Ramar, Kannan ^a   Caples, Sean M ^a  

^a Sleep and Critical Care Medicine   (United States)

Author keywords

Cardiovascular consequences; Obesity; Obstructive sleep apnea

Indexed keywords

APNEA HYPOPNEA INDEX; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DAYTIME SOMNOLENCE; DISEASE PREDISPOSITION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOXEMIA; INSULIN RESISTANCE; NONHUMAN; OBESITY; OXIDATIVE STRESS; OXYGEN SATURATION; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SNORING; SUDDEN DEATH;

CARDIOVASCULAR DISEASES; HUMANS; INTRA-ABDOMINAL FAT; OBESITY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 77951713418     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.02.003     Document Type: Review

References (95)

1. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230
2. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 104 (2001) 3052
3. McFarlane S.I., Banerji M., and Sowers J.R. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86 (2001) 713
4. Abate N. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14 (2000) 154
5. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001) 2486
6. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415
7. Gaziano J.M., Hennekens C.H., O'Donnell C.J., et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96 (1997) 2520
8. Genest Jr. J.J., Martin-Munley S.S., McNamara J.R., et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85 (1992) 2025
9. Jeppesen J., Hein H.O., Suadicani P., et al. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97 (1998) 1029
10. Alpert M.A. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321 (2001) 225
11. Messerli F.H., Nunez B.D., Ventura H.O., et al. Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity. Arch Intern Med 147 (1987) 1725
12. Lavie C.J., Milani R.V., Ventura H.O., et al. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 100 (2007) 1460
13. Lavie C.J., Amodeo C., Ventura H.O., et al. Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity. Chest 92 (1987) 1042
14. Garrison R.J., Kannel W.B., Stokes III J., et al. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 16 (1987) 235
15. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305
16. Alpert M.A., Terry B.E., Mulekar M., et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80 (1997) 736
17. Hubert H.B., Feinleib M., McNamara P.M., et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983) 968
18. Lavie C.J., and Milani R.V. Obesity and cardiovascular disease: the Hippocrates paradox?. J Am Coll Cardiol 42 (2003) 677
19. Wang T.J., Parise H., Levy D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004) 2471
20. Wanahita N., Messerli F.H., Bangalore S., et al. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 155 (2008) 310
21. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 113 (2006) 898
22. Kannel W.B., Plehn J.F., and Cupples L.A. Cardiac failure and sudden death in the Framingham Study. Am Heart J 115 (1988) 869
23. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666
24. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897
25. Li C., and Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282 (2002) C227
26. Shiomi T., Guilleminault C., Stoohs R., et al. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest 100 (1991) 894
27. Stoohs R., and Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 72 (1992) 583
28. Virolainen J., Ventila M., Turto H., et al. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 79 (1995) 455
29. Narkiewicz K., Kato M., Phillips B.G., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 (1999) 2332
30. O'Donnell C.P., Allan L., Atkinson P., et al. The effect of upper airway obstruction and arousal on peripheral arterial tonometry in obstructive sleep apnea. Am J Respir Crit Care Med 166 (2002) 965
31. Schneider H., Schaub C.D., Chen C.A., et al. Effects of arousal and sleep state on systemic and pulmonary hemodynamics in obstructive apnea. J Appl Physiol 88 (2000) 1084
32. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 (2005) 2660
33. Vongpatanasin W., Thomas G.D., Schwartz R., et al. C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation 115 (2007) 1020
34. Bokinsky G., Miller M., Ault K., et al. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 108 (1995) 625
35. Steiner S., Jax T., Evers S., et al. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 104 (2005) 92
36. Lee S.A., Amis T.C., Byth K., et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 31 (2008) 1207
37. Brooks D., Horner R.L., Kozar L.F., et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99 (1997) 106
38. Young T., Peppard P., Palta M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157 (1997) 1746
39. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378
40. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283 (1829) 2000
41. Haas D.C., Foster G.L., Nieto F.J., et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111 (2005) 614
42. Ali N.J., Davies R.J., Fleetham J.A., et al. The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 101 (1992) 1526
43. Dimsdale J.E., Loredo J.S., and Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 35 (2000) 144
44. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359 (2002) 204
45. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107 (2003) 68
46. Barbe F., Mayoralas L.R., Duran J., et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 134 (2001) 1015
47. Robinson G.V., Smith D.M., Langford B.A., et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27 (2006) 1229
48. Hui D.S., To K.W., Ko F.W., et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 61 (2006) 1083
49. Norman D., Loredo J.S., Nelesen R.A., et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 47 (2006) 840
50. Haentjens P., Van Meerhaeghe A., Moscariello A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167 (2007) 757
51. Bazzano L.A., Khan Z., Reynolds K., et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50 (2007) 417
52. Otto M.E., Belohlavek M., Romero-Corral A., et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99 (2007) 1298
53. Usui K., Parker J.D., Newton G.E., et al. Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med 173 (2006) 1170
54. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49 (2007) 565
55. Wang H., Parker J.D., Newton G.E., et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49 (2007) 1625
56. Marin J.M., Carrizo S.J., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046
57. Shepard Jr. J.W., Pevernagie D.A., Stanson A.W., et al. Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med 153 (1996) 250
58. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 (2003) 1233
59. Mansfield D.R., Gollogly N.C., Kaye D.M., et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169 (2004) 361
60. Smith L.A., Vennelle M., Gardner R.S., et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 28 (2007) 1221
61. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173 (2006) 910
62. Grimm W., Koehler U., Fus E., et al. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol 86 (2000) 688
63. Guilleminault C., Connolly S.J., and Winkle R.A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52 (1983) 490
64. Gami A.S., Pressman G., Caples S.M., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110 (2004) 364
65. Mitchell A.R., Spurrell P.A., and Sulke N. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. Am Heart J 146 (2003) 902
66. Kanagala R., Murali N.S., Friedman P.A., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107 (2003) 2589
67. van Boxem T.J., and de Groot G.H. Prevalence and severity of sleep disordered breathing in a group of morbidly obese patients. Neth J Med 54 (1999) 202
68. Vgontzas A.N., Tan T.L., Bixler E.O., et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154 (1994) 1705
69. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217
70. Fox C.S., Massaro J.M., Hoffmann U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116 (2007) 39
71. Ip M.S., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 (2002) 670
72. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 (2004) 521
73. Rader D.J. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120 (2007) S12
74. Grunstein R., Wilcox I., Yang T.S., et al. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 17 (1993) 533
75. Shinohara E., Kihara S., Yamashita S., et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 241 (1997) 11
76. Peppard P.E., Young T., Palta M., et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284 (2000) 3015
77. Young T., Shahar E., Nieto F.J., et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162 (2002) 893
78. Schwartz A.R., Gold A.R., Schubert N., et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 144 (1991) 494
79. Smith P.L., Gold A.R., Meyers D.A., et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 103 (1985) 850
80. Newman A.B., Foster G., Givelber R., et al. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 165 (2005) 2408
81. Phillips B.G., Hisel T.M., Kato M., et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 17 (1999) 1297
82. Phillips B.G., Kato M., Narkiewicz K., et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279 (2000) H234
83. Chin K., Shimizu K., Nakamura T., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 (1999) 706
84. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151
85. Ip M.S., Lam K.S., Ho C., et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118 (2000) 580
86. Shimizu K., Chin K., Nakamura T., et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 57 (2002) 429
87. Hall J.E. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 10 (1997) 49S
88. Hall J.E., Brands M.W., and Henegar J.R. Mechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci 892 (1999) 91
89. Engeli S., and Sharma A.M. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 79 (2001) 21
90. Moller D.S., Lind P., Strunge B., et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16 (2003) 274
91. Somers M.J., and Harrison D.G. Reactive oxygen species and the control of vasomotor tone. Curr Hypertens Rep 1 (1999) 102
92. Wilcox C.S. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4 (2002) 160
93. Punjabi N.M., Newman A.B., Young T.B., et al. Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas. Am J Respir Crit Care Med 177 (2008) 1150
94. Tamisier R., Gilmartin G.S., Launois S.H., et al. A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure. J Appl Physiol 107 (2009) 17
95. Peppard P.E., Ward N.R., and Morrell M.J. The impact of obesity on oxygen desaturation during sleep-disordered breathing. Am J Respir Crit Care Med 180 (2009) 788